Mice deficient in the smooth muscle Ca v 1.2 calcium channel (SMACKO, smooth muscle α 1c -subunit calcium channel knockout) have a severely reduced micturition and an increased bladder mass. L-type calcium current, protein, and spontaneous contractile activity were absent in the bladder of SMACKO mice. K + and carbachol (CCh)-induced contractions were reduced to 10-fold in detrusor muscles from SMACKO mice. The dihydropyridine isradipine inhibited K + -and CCh-induced contractions of muscles from CTR but had no effect in muscles from SMACKO mice. CCh-induced contraction was blocked by removing extracellular Ca 2+ but was unaffected by the PLC inhibitor U73122 or depletion of intracellular Ca 2+ stores by thapsigargin. In muscles from CTR and SMACKO mice, CCh-induced contraction was partially inhibited by the Rhokinase inhibitor Y27632. These results show that the Ca v 1.2 Ca 2+ channel is essential for normal bladder function. The Rho-kinase and Ca 2+ -release pathways cannot compensate the lack of the L-type Ca 2+ channel.
Furthermore, it was suggested that stimulation of muscarinic receptors can induce contraction independent of changes in [Ca 2+ ] i through the Rho/Rho-kinase pathway and inhibition of myosin phosphatase (3, 21).
To clarify the physiological significance of the Ca v 1.2 Ca 2+ channel for the phasic and tonic contractions of bladder smooth muscle, we used tamoxifen-activated, smooth muscle-specific mutagenesis (22) to inactivate the Ca v 1.2 gene in mice (23). These conditional Ca v 1.2 mutants allow a very precise analysis of the role of Ca v 1.2 in bladder smooth muscle contraction compared with the use of pharmacological tools such as Ca 2+ channel antagonists, which may cause effects unrelated to Ca 2+ channels (24, 25). Our analysis indicates that the Ca v 1.2 channel in murine urinary bladder is critically involved in i) the spontaneous contractile activity and ii) contraction induced by cholinergic stimulation.
MATERIAL AND METHODS

Generation of mice
All experiments conformed with the animal protection laws of Germany. The generation of mice deficient in the smooth muscle Ca v 1.2 calcium channel (SMACKO, smooth muscle α 1c -subunit calcium channel knockout) has recently been described (23). Briefly, a conditional loxP-flanked allele (L2) of the Ca v 1.2 gene (i.e., exons 14 and 15) was generated by homologous recombination in R1 embryonic stem cells (Fig. 1a) . In addition, mice carried a knock-in allele [SM-CreER T2 (ki), (22)], which expresses the tamoxifen-dependent Cre recombinase, CreER T2 , from the endogenous SM22α gene locus, which is selectively expressed in smooth muscle of adult mice. Thus, tamoxifen treatment of mice should result in conversion of the loxP-flanked Ca v 1.2 allele (L2) into a Ca v 1.2 knockout allele (L1) specifically in smooth muscle cells. Animals were kept under standard conditions with water and food ad libitum. At an age of 3 to 12 months, SMACKO mice (Ca v 1.2 L1/L2 , SM-CreER T2 (ki) +/− ) and corresponding control (CTR) mice (Ca v 1.2 +/L2 , SM-CreER T2 (ki) +/− ) were i.p. injected with tamoxifen (1 mg per day) for 5 consecutive days. After 3-4 weeks, mice were killed by cervical dislocation and the urinary bladder was removed. Experiments were performed on the same day with bladders from litter-or age-matched CTR and SMACKO mice. Wild-type (WT) mice were examined in parallel; results obtained from WT and CTR animals did not differ statistically, indicating that tamoxifen treatment and/or the presence of the SM-CreER T2 (ki) allele had no effect by itself on the parameters measured. Salts and drugs used were at least of reagent grade and were purchased from Sigma (www.sigma-aldrich.com) and Calbiochem (www.calbiochem.com), respectively, unless otherwise indicated. Micturition was measured as described (26).
RT-PCR of urinary bladder
PolyA-mRNA was isolated from the urinary bladder (10 mg) by using Dynabeads Oligo (dT) 25 (www.dynalbiotech.com) as described previously (27). The following primers were used: for Ca v 1. 2 (VS9 5′-ACA CAG CCA ATA AAG CCC TCC TG-3′ and VS18 5′-GGC CAG CTT  CTT CCT CTC CTT-3′); for hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) (QG  197 5′-GTA ATG ATC AGT CAA CGG GGG AC-3′ and QG 198 5′-CCA GCA AGC TTG  CAA CCT TAA CCA-3′); for splice variants of Ca v 1.2 (Hex1-2 5′-GCT-CAA-CTC-AAC-CAT-TTC-TAC-A-3′; VS-2 3′-CCT-ACA-ACC-ACG-ATT-ATA-AAA-TCC-5′ and CS2-1 3′-AGG-ATG-TAC-GTT-CCA-GAG-GA-5′) (28) .
Western blot
Microsomal membranes were prepared from urinary bladder and solubilized as described (29) . Membrane fractions were separated by SDS-PAGE and were electrotransferred to polyvinylidene difluoride membranes. Blots were blocked with 5% nonfat milk powder in TRISbuffered saline and labeled with anti-Ca v 1.2 antibody (www.chemicon.com).
Tension recordings
Urinary bladder was immersed in warmed (37°C) and oxygenated buffer solution (containing in mM: NaCl 137, KCl 5.4, CaCl 2 1.8, MgCl 2 1, NaHCO 3 12, NaH 2 PO 4 0.42, glucose 5.6; aerated with 95% O 2 + 5% CO 2 ; pH 7.4). Four longitudinal muscle strips (2 × 5 mm) were prepared from detrusor muscle and supplied at either end with silk ligatures. The muscle strips were mounted to muscle holders located in organ baths (Myograph 601, www.dmt.dk) containing oxygenated buffer solution at 36 ± 1°C. Tension was recorded isometrically. Resting tension was set to 5-10 mN. Depolarization was achieved by exchanging equimolar Na + with K + . Drugs were applied as a single dose or cumulatively to achieve the concentrations as indicated. Cumulative concentration-effect curves for CCh or K + were obtained in the absence and presence of a test substance (repeated measurement design). Inhibitors or activators (test substances) were applied 10-20 min before initiation of contraction.
Isolation of single smooth muscle cells
Urinary bladder tissue was cut into small pieces and initially placed in 2 ml of dissociation solution for 10 min (containing in mM: NaCl 137, KCl 5.4, MgCl 2 1, NaHCO 3 12, NaH 2 PO 4 0.42, glucose 10.6; aerated with 95% O 2 + 5% CO 2 ; pH 7.4). Then, the pieces were transferred to 2 ml of dissociation solution containing 1 mg/ml papain, 1 mg/ml dithioerythreitol, and 1 mg/ml bovine serum albumin. The tissue pieces were incubated at 37°C for 25 min, after which they were transferred to a solution containing 1 mg/ml collagenase XI, 1 mg/ml bovine serum albumin, and 100 µM Ca
2+
. Following an incubation of 6-7 min, the digested tissue was washed several times in dissociation solution and triturated to yield single smooth muscle cells. About 10 to 33% of the cells were elongated and had a bright, shiny appearance when examined by phasecontrast microscopy.
Current recordings
Whole-cell currents from single myocytes were measured by using conventional patch clamp technique at room temperature. The patch pipettes were built from borosilicate glass (www.harvardapparatus.com) and had resistances of 2.8-4 MΩ when filled with pipette solution (in mM: 112 CsCl, 1 MgSO 4 , 3 Na 2 ATP, 10 EGTA, 5 HEPES; pH was adjusted to 7.4 with CsOH). Bath solution contained (in mM) 115 NaCl, 20 TEA-Cl, 5.4 KCl, 0.33 NaH 2 PO 4 , 5 HEPES, 1 MgCl 2 , 2 BaCl 2 , and 5.5 glucose; pH was adjusted to 7.4 with NaOH. The holding potential was -80 mV. L-type Ca 2+ channel currents were elicited by depolarizing voltage steps of 400 ms from -60 to 50 mV in 10 mV increments at 0.1 Hz before and after application of the dihydropyridine isradipine (ISR, 1 µM). Data were collected at 2.5 kHz, filtered at 833 Hz, and stored at an IBM-compatible computer using the patch clamp amplifier EPC-9 and PULSE software 8.50 (www.heka.com). Currents recorded were not compensated for capacity or leak currents.
Recording of intracellular [Ca 2+ ]
Intracellular [Ca 2+ ] was monitored at ~35°C as described (30) . Briefly, isolated myocytes from urinary bladder were loaded with 3 µM Fura-2/AM (www.calbiochem.com) for 30 min in buffer solution (in mM: NaCl 137, KCl 5.4, CaCl 2 1.8, MgCl 2 
Evaluation of results
Results are presented as images of gels and blots, original recordings, or expressed as means ± SEM. Effects of drugs were analyzed in quasi steady-state conditions. The magnitude of currents was measured as the difference between peak inward and steady-state current at -80 mV. Changes in tension were determined with respect to the resting tension before stimulation. Phasic responses to stimulation were measured at maximum, whereas tonic responses were measured 5 min after stimulation. Statistical comparisons of datasets were performed by a Student's t-test. Differences were considered significant at P < 0.05.
RESULTS
Phenotypic analysis of smooth muscle specific knockout mice
The conventional inactivation of the Ca v 1.2 gene leads to embryonic lethality before Day 14.5 p.c. (31) . Therefore, we used a conditional approach ( (Fig. 1D ). In line with this, L-type Ba 2+ current were present in bladder myocytes from CTR mice (Fig. 1E , G), but missing in cells from SMACKO mice (Fig. 1F, H) . Isradipine (1 µM) reduced the current in myocytes from CTR but not from SMACKO mice. Both types of myocytes showed a T-type-like current which was insensitive to 1 µM isradipine ( Fig. 1E-H ). The densities of T-type-like peak currents at -30 mV did not differ in CTR and SMACKO mice (in pA/pF: -1.15 ± 0.43; n=4 and -1.09 ± 0.15, respectively; n=11; P>0.05), ruling out a compensatory change in the density of this and other voltage-dependent calcium channels.
As a functional consequence of Ca v 1.2 gene inactivation, SMACKO mice developed bladder dysfunction characterized by diminished micturition (Fig. 1I ) and urinary retention reflected by extreme distension of the bladder. In addition, the weight of bladder, but not of the heart or whole body (Fig. 1J ), was larger in SMACKO mice than in CTR mice, which suggests bladder hypertrophy. In agreement with a hypertrophy, cell capacitance was larger in myocytes from SMACKO than from CTR mice (in pF: 68 ± 13, n=4 and 32 ± 5, n=11, respectively; P<0.01).
Ca v 1.2 and source of calcium
The absence of a functional Ca v 1.2 channel was further shown by experiments monitoring changes in [Ca 2+ ] i in Fura-2 loaded myocytes ( Fig. 2A, B) . Depolarization by 85 mM K + increased [Ca 2+ ] i levels in bladder myocytes from CTR but not from SMACKO mice ( Fig. 2A) . CCh (10 µM) induced [Ca 2+ ] i -signals in myocytes from both CTR and SMACKO mice. The areas under the curves (in units) were 53 ± 6 (n=12) and 39 ± 6 (n=9) for CTR and SMACKO mice, respectively. Pretreatment with isradipine reduced the CCh-induced Ca 2+ transient in myocytes from CTR but not in those from SMACKO mice (Fig. 2B) ] i increase was caused by influx from the extracellular compartment (see below).
The Ca v 1.2 channel is also required for rhythmic contraction of the bladder. The detrusor, a phasic smooth muscle, showed spontaneous contractile activity if slightly depolarized by an extracellular [K + ] of 30 mM (Fig. 2C) . Spontaneous activity was also induced in CTR muscles by 10 µM CCh (Fig. 2D) . In contrast, detrusor from SMACKO mice lacked any spontaneous activity. These results indicate that Ca v 1.2 channel is crucial for rhythmic muscle activity and cannot be replaced by T-type Ca 2+ current as previously suggested (32) .
Ca v 1.2 and bladder contraction
Depolarization of bladder muscle strips by high K + (85 mM) elicited contraction consisting of a phasic followed by a tonic contractile component. Both components were significantly larger in muscles from CTR than from SMACKO mice (Fig. 3A) . Pre-incubation with 1 µM isradipine reduced significantly the phasic and tonic component in muscles from CTR but only nonsignificantly in muscles from SMACKO mice (Fig. 3A) . Contraction of CTR, but not of SMACKO, muscles was inhibited by isradipine with an IC 50 of 0.25 ± 0.1 nM (n=10), confirming that the contraction was associated with an influx of Ca 2+ through Ca v 1.2 channels. Stimulation with CCh induced contraction with an EC 50 of 1.1 ± 0.1 µM (n=14), which also consisted of a phasic followed by a tonic contractile component in detrusor muscle strips (Fig.  3B ). Both components were significantly smaller in smooth muscles from SMACKO mice than in those from CTR mice (Fig. 3B) . Isradipine (1 µM; Fig. 3B ), as well as cadmium (300 µM; not shown), reduced the CCh stimulated phasic and tonic contraction of muscles from CTR mice (P<0.001, respectively) but not of those from SMACKO mice (P>0.05, respectively). These results suggest that both components of CCh-induced contraction depended on calcium influx through the Ca v 1.2 channel. To further validate this hypothesis, we added 10 mM BAPTA to the bath to reduce the extracellular [Ca 2+ ] from 1.8 mM to ~34 nM. To prevent a marked reduction of the intracellular stored calcium, CCh was added 20 s after BAPTA. This procedure has been used to evaluate extracellular Ca 2+ influx without affecting significantly intracellular calcium stores (33) . Fig. 3B shows that addition of BAPTA reduced significantly the phasic CCh response in muscles from CTR bladder and to a lesser degree in muscles from SMACKO mice. However, CCh was unable to induce a contraction, when overall [Ca 2+ ] was reduced by incubating muscle strips for 15 min in nominal Ca 2+ free extracellular solution containing 1 mM EGTA (Fig. 3C) . Taken together these findings support further the hypothesis that contraction depended critically on the influx of Ca 2+ through the L-type Ca v 1.2 channel.
Calcium stores and contraction
The results presented so far did not unambiguously clarify to what extent the CCh-induced contraction depended on Ca 2+ influx via Ca v 1.2 channels or on Ca 2+ release from intracellular stores. To address this issue, we depleted intracellular calcium stores by treatment with thapsigargin (TG; 34). Thapsigargin (1 µM) induced a tiny tonic contraction (Fig. 3C) , which was more pronounced in muscles from SMACKO than in those from CTR mice [in N/g: 0.47 ± 0.07 (n=14) and 0.28 ± 0.04 (n=15), respectively, P<0.05]. Surprisingly, pre-incubation for 30 min with thapsigargin did not influence the contractile phasic responses of bladder muscle to CCh, regardless of the genotype (Fig. 3C) . Further support for this result comes from experiments in which phospholipase C was inhibited by the compound U73122 (10 µM; Fig. 4A ) and 2-nitro-4-carboxyphenyl-N,N-diphenyl-carbamate (100 µM, not shown). Neither of these compounds affected CCh-induced phasic contractions. Similar findings have been reported recently in rat bladder (35) . These results demonstrate that phasic contraction induced by muscarinergic stimulation of murine bladder smooth muscle, prominent for bladder emptying, depends mainly on Ca 2+ influx via Ca v 1.2 channels and argue against a significant contribution of Ca 2+ release from intracellular stores.
In contrast, the tonic contractile component of the CCh-induced contraction was reduced roughly by 50% by treatment with TG ( Fig. 3C ) but only by 10% by U73122 (not shown) in muscles from both CTR and SMACKO mice. Thus, Ca
2+
-release from intracellular stores contributed only partially to the tonic component of CCh-induced contractions.
Possibly, the Ca 2+ content of the intracellular Ca 2+ stores was too low to release a significant amount of Ca 2+ upon CCh stimulation. We repeated the above experiments in conditions that increase the intracellular [Ca 2+ ]. Depolarization of the muscles with high K + (85 mM) for 5 min doubled the effects of TG (1 µM) and even that of the PLC activator m-3M3FBS (100 µM) on tension. The force developed by TG in the presence and absence of K + depolarization was (in N/g) 0.5 ± 0.07 (n=14) and 0.28 ± 0.04 (n=15), respectively, and that induced by m-3M3FBS was (in N/g) 0.04 ± 0.02 (n=6) and 0.12 ± 0.02 (n=8), respectively. These values indicate an increased filling of the Ca 2+ stores. Pre-incubation with TG (1 µM) or U73122 (10 µM) now attenuated the CCh-induced phasic contractions by 14 and 17%, respectively. Thus, under conditions of increased intracellular [Ca 2+ ], Ca 2+ release from intracellular stores contributed slightly to CCh-induced phasic contractions.
Muscarinic receptor coupling
Murine urinary bladder smooth muscle express M 3 and M 2 receptors, coupling to G q/11 and G 12/13 , respectively (36, 37) . These G proteins are known to activate a number of cellular signaling pathways, including PLC/IP 3 /DAG and Rho/Rho-kinase (3, 21). The experiments described so far do not support a role of Ca 2+ release triggered by IP 3 in CCh-induced contractions. However in most experiments, there was a small component of contraction not requiring Ca 2+ influx that was possibly caused by the Rho/Rho-kinase pathway. Incubation of CTR and SMACKO muscle strips with the Rho-kinase inhibitor Y27632 (20 µM) reduced CChstimulated contraction by ~40 and 80 %, respectively (Fig. 4B) . Thus, the CCh-induced contractions of SMACKO muscle, but not of CTR muscle, are mostly caused by Rho-kinasedependent inhibition of myosin phosphatase. However, bladder contractions in SMACKO mice reached only ~25% of those observed in CTR mice (Fig. 3B) , indicating that the Rho-kinase pathway is insufficient to compensate the loss of Ca v 1.2 function. Because both types of muscles were affected by the Rho-kinase inhibitor, this contraction did not require coupling between the muscarinic receptors and the Ca v 1.2 channel.
Potential targets for the Rho-kinase are MYPT-1 and the small protein CPI-17 that inhibit myosin phosphatase leading to contraction (3). CPI-17 is also phosphorylated by PKC (38) . In agreement with the inability of the PLC inhibitors to affect the CCh-induced contraction, various PKC inhibitors also did not affect CCh-induced contractions (not shown). However, it was possible that external activation of PKC by a phorbolester might lead to phosphorylation of CPI-17 affecting contraction via the Rho-kinase pathway. In addition, PKC could increase Ca 2+ influx via phosphorylation of the Ca v 1.2a isoform (39) that was expressed in bladder smooth muscle (see Fig. 1B ). Activation of PKC by phorbol 12,13-dibutyrate (PdBu) shifted the concentrationresponse curves for CCh (not shown) and K + (Fig. 4C) to the left in muscles from CTR but not from SMACKO mice. The specificity of the phorbolester effect was ascertained by inhibition of the shift by the PKC inhibitor Gö6850 (Fig. 4D) . Thus, the phosphorylation state of CPI-17 and/or the Ca v 1.2a channel may have functional consequences in CTR bladder muscle, but not in muscles from SMACKO mice. These results clearly show that contraction of detrusor smooth muscle is controlled mainly by influx of Ca 2+ through the L-type Ca v 1.2 channel. The Rhokinase pathway may regulate the sensitivity of the Ca 2+ dependent regulatory system, but is insufficient to produce the force required to empty the bladder.
DISCUSSION
In the present study, the Ca v 1.2 gene was inactivated in urinary bladder from mice by using a smooth muscle-specific tamoxifen-activated Cre/lox system (22). The inactivation of the Ca v 1.2 gene in bladder muscle was confirmed by the lack of protein and L-type calcium channel current. The absence of the Ca v 1.2 protein resulted in the lack of rhythmic contractions and the reduction of contractile responses to external stimuli. SMACKO mice show severe difficulties to urinate as evidenced by reduced micturition. These results show that the Ca v 1.2 channel is critically involved in bladder function.
A major finding of this study is that stimulation of bladder contraction by muscarinic acetylcholine receptors depended mostly on the presence of the Ca v 1.2 channel. The decisive experiments for this conclusion are that i) stimulus-induced tension in muscle strips from SMACKO mice is almost 4× smaller than in CTR mice; ii) short-term removal of extracellular Ca 2+ by BAPTA prevented CCh-induced contraction; and iii) pre-incubation with thapsigargin had no effect on CCh-induced contraction. The small residual contraction induced by CCh in muscles from SMACKO mice is in part due to activation of the Ca 2+ -independent Rho/Rhokinase pathway and in part to an unidentified Ca 2+ influx pathway.
Pharmacological activation of PKC potentiated depolarization-induced contractions in CTR but not SMACKO muscles, which suggests that the influx of Ca 2+ via Ca v 1.2 channels was essential for this effect. This result is in line with two possibilities: PKC affected the opening of the Ca v 1.2a calcium channel isoform (39) , which is present in bladder muscle (see Fig. 1B ) or the Rho-kinase pathway depends on Ca 2+ influx as shown for vascular smooth muscle (40) .
The coupling mechanism between muscarinic receptors and Ca v 1.2 channels is unclear. Although a very recent study has postulated that coupling of Cav1.2 and muscarinic receptors involves PI 3 -kinase and PKC in vascular myocytes (41) , inhibitors of PLC, PI 3 -kinase and PKC had either no effect or directly blocked Ca 2+ channels (Wegener and Welling, unpublished results). We can rule out the possibility that release of Ca 2+ from intracellular stores by activating muscarinergic receptors activates directly myosin light chain kinase and contraction. However, this Ca 2+ may activate the Ca v 1.2 channel via activation of Ca
2+
-dependent Cl -channels. However, it is also possible that CCh is linked to L-type Ca 2+ current in murine bladder by a more direct pathway that shifts the voltage activation curve of this channel toward hyperpolarized membrane potentials as described for tracheal smooth muscle (42) .
In conclusion, this study clearly identified the Ca v 1.2 channel as an essential part of the regulation of bladder contractility. Interestingly, inactivation of the M 3 , M 2 or both receptors does not grossly affect the in vivo and in vitro function of murine bladder (5, 43) . Obviously, emptying of the bladder is triggered by other signaling systems, e.g., purinergic receptors (44), in these mice. These alternative pathways converge toward an activation of Ca v 1.2 channels as a common mediator of contraction, since the lack of the Ca v 1.2 channel strongly affects bladder function. Release of Ca 2+ from intracellular stores, Ca 2+ entry via non-Ca v 1.2 channels, and the inhibition of myosin phosphatase via Rho/Rho-kinase signaling cannot compensate the lack of the Ca v 1.2 channel. Thus, our study challenges the generality of the hypothesis that hormone triggered smooth muscle contraction depends mainly on intracellular calcium release via IP 3 and/or on a calcium-independent signaling pathway. T ) and SMACKO (L1/L2 T ) mice after treatment with tamoxifen. Western blots of the membrane (pellet) and cytosolic fraction are shown. E-H) I Ba of detrusor myocytes of CTR (E, G) and SMACKO (F, H) mice. E, F). Original recordings in the absence (control) and presence of 1 µM isradipine (ISR). Currents were activated by depolarisation from -80 mV to 0 mV. G, H) Voltage current relation. Data points represent means ± SEM (n=4-12). I) Urine spots of freely moving male mice. **P< 0.01. J) Wet weight of the bladder, heart, and body from CTR and SMACKO mice. n = 9-15 animals; n.s., non-significant; ***P< 0.001. Test substances were (A) the PLC inhibitor U73122 (10 µM), (B) the Rho-kinase inhibitor Y27632 (20 µM), (C) the PKC activator PdBu (10 nM), and (D) both the PKC inhibitor Gö6850 (10 µM) and PdBu (10 nM). Values shown are mean ± SEM (n=3-16). In (C), the EC 50 for K + was shifted from 44 to 8 mM.
